HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 479 filers reported holding HORIZON THERAPEUTICS PUB L in Q3 2023. The put-call ratio across all filers is 2.95 and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,260 | -90.1% | 10,895 | -91.2% | 0.02% | -91.1% |
| Q2 2023 | $12,780 | +6.1% | 124,257 | +12.6% | 0.26% | 0.0% |
| Q1 2023 | $12,042 | -4.1% | 110,336 | 0.0% | 0.26% | -8.9% |
| Q4 2022 | $12,556 | -99.8% | 110,336 | -0.4% | 0.28% | +66.9% |
| Q3 2022 | $6,854,000 | -22.3% | 110,745 | +0.2% | 0.17% | -18.0% |
| Q2 2022 | $8,819,000 | -5.2% | 110,575 | +25.1% | 0.21% | -24.8% |
| Q1 2022 | $9,301,000 | +19.3% | 88,408 | +22.2% | 0.27% | +25.7% |
| Q4 2021 | $7,797,000 | -4.3% | 72,354 | -2.7% | 0.22% | -27.3% |
| Q3 2021 | $8,148,000 | +42.4% | 74,382 | +21.7% | 0.30% | +28.8% |
| Q2 2021 | $5,723,000 | +469.5% | 61,120 | +459.8% | 0.23% | +429.5% |
| Q1 2021 | $1,005,000 | +25.8% | 10,918 | 0.0% | 0.04% | +18.9% |
| Q4 2020 | $799,000 | +71.8% | 10,918 | +82.3% | 0.04% | -40.3% |
| Q3 2020 | $465,000 | – | 5,989 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |